Free Trial

Kura Oncology (KURA) Short Interest Ratio & Short Volume

Kura Oncology logo
$7.26 +0.08 (+1.11%)
As of 01/17/2025 04:00 PM Eastern

Kura Oncology Short Interest Data

Kura Oncology (KURA) has a short interest of 10.44 million shares, representing 16.00% of the float (the number of shares available for trading by the public). This marks a 17.44% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.3, indicating that it would take 6.3 days of the average trading volume of 1.40 million shares to cover all short positions.

Current Short Interest
10,440,000 shares
Previous Short Interest
8,890,000 shares
Change Vs. Previous Month
+17.44%
Dollar Volume Sold Short
$90.93 million
Short Interest Ratio
6.3 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
77,760,000 shares
Float Size
65,230,000 shares
Short Percent of Float
16.00%
Today's Trading Volume
1,174,495 shares
Average Trading Volume
1,398,863 shares
Today's Volume Vs. Average
84%
Short Selling Kura Oncology?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Kura Oncology and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

KURA Short Interest Over Time

KURA Days to Cover Over Time

KURA Percentage of Float Shorted Over Time

Kura Oncology Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/202410,440,000 shares $90.93 million +17.4%16.0%6.3 $8.71
12/15/20248,890,000 shares $85.61 million +21.6%13.6%5.9 $9.63
11/30/20247,310,000 shares $80.70 million -33.7%11.2%5.8 $11.04
11/15/202411,030,000 shares $175.60 million +2.1%17.0%10.6 $15.92
10/31/202410,800,000 shares $180.58 million +16.3%16.4%20.8 $16.72
10/15/20249,290,000 shares $169.17 million -8.8%14.3%17 $18.21
9/30/202410,190,000 shares $199.11 million -5.2%15.7%17.6 $19.54
9/30/20245,430,000 shares $1.06 million +320.9%N/A1.9 $0.20
9/15/202410,750,000 shares $224.46 million -0.5%16.6%16.9 $20.88
9/15/20241,290,000 shares $214,656.00 +8.4%N/A0.4 $0.17
8/31/202410,800,000 shares $227.45 million +3.9%16.7%16 $21.06
8/31/20241,190,000 shares $222,173.00 -22.2%N/A0.2 $0.19
8/15/202410,400,000 shares $202.28 million +12.3%16.0%14.6 $19.45
8/15/20241,530,000 shares $289,017.00 -11.1%N/A0.2 $0.19
7/31/20249,260,000 shares $192.70 million +4.0%14.3%12.5 $20.81
7/31/20241,720,000 shares $381,152.00 +74.9%N/A0.2 $0.22
7/15/20248,900,000 shares $202.65 million +1.8%13.8%12 $22.77
7/15/2024983,600 shares $279,834.20 -65.5%N/A0.1 $0.28
6/30/20248,740,000 shares $179.96 million -11.2%13.5%11.8 $20.59
6/30/20242,850,000 shares $769,785.00 +99.3%N/A0.2 $0.27
6/15/20249,840,000 shares $204.87 million -0.4%15.2%13.7 $20.82
6/15/20241,430,000 shares $262,119.00 -69.8%N/A0.1 $0.18
5/31/20249,880,000 shares $203.63 million -4.2%15.3%12.5 $20.61
5/31/20244,740,000 shares $1.47 million +319.5%N/A0.3 $0.31
5/15/202410,310,000 shares $225.48 million -0.4%16.3%12.1 $21.87
5/15/20241,130,000 shares $148,143.00 -72.0%N/A0.1 $0.13
4/30/202410,350,000 shares $203.07 million +2.3%N/A11.4 $19.62
4/30/20244,040,000 shares $627,412.00 +477.1%N/A0.3 $0.16
4/15/202410,120,000 shares $192.38 million -2.8%15.9%7.2 $19.01
4/15/2024700,000 shares $77,070.00 +6.2%N/A0.1 $0.11
3/31/202410,410,000 shares $222.05 million +1.1%16.4%7.4 $21.33
3/31/2024658,900 shares $68,525.60 -70.1%N/A0 $0.10
3/15/202410,300,000 shares $230.10 million -6.5%16.2%7.3 $22.34
3/15/20242,200,000 shares $207,020.00 +0.5%N/A0.2 $0.09
2/29/202411,020,000 shares $232.30 million +4.9%17.4%7 $21.08
2/29/20242,190,000 shares $234,330.00 +432.7%N/A0.2 $0.11
2/15/202410,510,000 shares $215.56 million +12.2%16.3%7.1 $20.51
2/15/2024411,100 shares $44,028.81 +150.7%N/A0 $0.11
1/31/20249,370,000 shares $188.71 million No Change14.3%6.2 $20.14
1/31/2024164,000 shares $23,747.20 -59.7%5.0%0 $0.14
1/15/20249,370,000 shares $144.02 million +1.2%14.3%9.4 $15.37
1/15/2024407,100 shares $56,953.29 +234.8%12.3%0.1 $0.14
12/31/20239,260,000 shares $133.16 million -15.9%14.1%8.9 $14.38
12/31/2023121,600 shares $20,623.36 -60.4%3.7%0 $0.17
12/15/202311,010,000 shares $135.42 million -0.6%16.7%11.1 $12.30
12/15/2023306,900 shares $60,766.20 -12.8%9.3%0.3 $0.20
11/30/202311,080,000 shares $107.14 million +1.9%16.8%14.3 $9.67
11/30/2023352,000 shares $119,680.00 -34.6%10.9%0.5 $0.34
11/15/202310,870,000 shares $101.96 million +7.6%16.5%14.5 $9.38
11/15/2023538,500 shares $189,228.90 +541.8%32.3%1.3 $0.35
10/31/202310,100,000 shares $85.35 million +38.6%15.3%15.4 $8.45
10/31/202383,900 shares $62,664.91 +126.2%5.0%0.6 $0.75
10/15/20237,290,000 shares $61.53 million +4.1%11.1%11.4 $8.44
10/15/202337,100 shares $127,253.00 +152.4%2.2%2.1 $3.43
9/30/20237,000,000 shares $63.84 million +9.9%10.6%12.2 $9.12
9/30/202314,700 shares $59,388.00 +53.1%0.9%0.9 $4.04
9/15/20236,370,000 shares $63.00 million +3.8%9.7%10.3 $9.89
9/15/20239,600 shares $39,936.00 -66.6%0.6%0.1 $4.16
8/31/20236,140,000 shares $60.97 million -1.4%N/A7.8 $9.93
8/31/202328,700 shares $130,585.00 +38.0%1.8%0.2 $4.55
8/15/20236,230,000 shares $72.95 million +3.0%N/A7.2 $11.71
8/15/202320,800 shares $68,640.00 -23.3%1.2%0.1 $3.30
7/31/20236,050,000 shares $63.16 million -4.1%N/A6.8 $10.44
7/31/202327,100 shares $120,866.00 -46.6%1.6%0.2 $4.46
7/15/20236,310,000 shares $63.35 million +1.3%N/A7.1 $10.04
7/15/202350,700 shares $235,248.00 -9.8%3.1%0.3 $4.64
6/30/20236,230,000 shares $65.91 million -16.3%N/A7.2 $10.58
6/30/202356,200 shares $226,486.00 +200.5%3.4%0.3 $4.03
6/15/20237,440,000 shares $81.54 million +21.2%N/A9 $10.96
6/15/202318,700 shares $70,125.00 -26.4%1.1%0.5 $3.75
5/31/20236,140,000 shares $81.78 million -21.8%9.6%9.6 $13.32
5/31/202325,400 shares $81,534.00 +75.2%1.5%0.6 $3.21
5/15/20237,850,000 shares $99.38 million -0.4%12.4%12.5 $12.66
5/15/202314,500 shares $43,500.00 +12.4%0.9%0.3 $3.00
4/30/20237,880,000 shares $76.75 million -0.1%12.5%13.4 $9.74
4/30/202312,900 shares $35,733.00 -41.9%0.8%0.3 $2.77
4/15/20237,890,000 shares $90.26 million -3.8%12.5%12.9 $11.44
4/15/202322,200 shares $63,025.80 -12.9%1.4%0.9 $2.84
3/31/20238,200,000 shares $100.29 million +15.5%15.3%12.8 $12.23
3/31/202325,500 shares $89,989.50 +390.4%1.6%0.9 $3.53
3/15/20237,100,000 shares $83.00 million +0.1%11.0%10.6 $11.69
3/15/20235,200 shares $17,108.00 -85.4%0.3%0.1 $3.29
2/28/20237,090,000 shares $84.51 million +5.4%11.0%8.6 $11.92
2/28/202335,600 shares $177,644.00 +65.6%2.2%0.5 $4.99
2/15/20236,730,000 shares $81.37 million +1.1%10.5%8.1 $12.09
2/15/202321,500 shares $130,075.00 +9.7%1.3%0.1 $6.05
1/31/20236,660,000 shares $92.04 million +5.4%10.3%7.5 $13.82
1/31/202319,600 shares $123,480.00 -14.4%1.2%0.1 $6.30
1/15/20236,320,000 shares $90.38 million -2.5%9.8%6.2 $14.30
1/15/202322,900 shares $162,819.00 -42.2%1.5%0.1 $7.11
12/30/20226,480,000 shares $80.42 million +2.4%10.0%6.2 $12.41
12/30/202239,600 shares $272,844.00 -56.3%2.7%0.1 $6.89
12/15/20226,330,000 shares $80.39 million -11.5%9.8%5.7 $12.70
12/15/202290,600 shares $834,426.00 -75.7%N/A0.2 $9.21
11/30/20227,150,000 shares $112.76 million +2.4%11.1%6.8 $15.77
11/30/2022373,400 shares $2.50 million +614.0%N/A1 $6.70
11/15/20226,980,000 shares $106.79 million +11.0%10.8%6.9 $15.30
11/15/202252,300 shares $208,154.00 -97.4%N/A0.9 $3.98
10/31/20226,290,000 shares $97.62 million -12.6%9.8%6.6 $15.52
10/31/20222,040,000 shares $219,708.00 +196.3%N/A0.9 $0.11
10/15/20227,200,000 shares $108.79 million -3.5%11.4%8.1 $15.11
10/15/2022688,400 shares $65,535.68 -16.8%N/A0.2 $0.10
9/30/20227,460,000 shares $101.90 million -7.8%11.8%8.4 $13.66
9/30/2022827,000 shares $89,316.00 +2.2%N/A0.3 $0.11
9/15/20228,090,000 shares $118.11 million -0.4%12.8%9.5 $14.60
9/15/2022808,900 shares $128,210.65 -11.3%N/A0.3 $0.16
8/31/20228,120,000 shares $112.54 million +4.5%12.8%10 $13.86
8/31/2022911,400 shares $141,358.14 -31.0%N/A0.3 $0.16
8/15/20227,770,000 shares $127.97 million +27.8%12.3%10 $16.47
8/15/20221,320,000 shares $245,784.00 +686.7%N/A0.4 $0.19
7/31/20226,080,000 shares $93.08 million +14.5%9.7%7.4 $15.31
7/31/2022167,800 shares $31,730.98 -56.4%N/A0 $0.19
7/15/20225,310,000 shares $95.26 million +9.3%8.4%7.1 $17.94
7/15/2022384,500 shares $94,548.55 -65.1%N/A0.1 $0.25
6/30/20224,860,000 shares $89.08 million +0.2%7.7%7.3 $18.33
6/30/20221,100,000 shares $305,800.00 +158.5%N/A0.3 $0.28
6/15/20224,850,000 shares $68.05 million +10.2%7.7%8 $14.03
6/15/2022425,500 shares $99,439.35 -35.1%N/A0.1 $0.23
5/31/20224,400,000 shares $57.90 million +7.8%7.0%7.5 $13.16
5/31/2022655,700 shares $118,026.00 +42.1%N/A0.2 $0.18
5/15/20224,080,000 shares $47.41 million +30.8%6.5%6.5 $11.62
5/15/2022461,600 shares $86,780.80 -64.5%N/A0.2 $0.19
4/30/20223,120,000 shares $44.77 million +8.7%5.0%4.2 $14.35
4/30/20221,300,000 shares $377,000.00 +157.6%N/A0.7 $0.29
4/15/20222,870,000 shares $46.29 million -1.4%4.6%3.5 $16.13
4/15/2022504,700 shares $160,999.30 +76.7%N/A0.4 $0.32
3/31/20222,910,000 shares $46.79 million -14.7%4.7%3.4 $16.08
3/31/2022285,600 shares $113,640.24 -17.5%N/A0.3 $0.40
3/15/20223,410,000 shares $51.46 million -15.6%5.5%3.9 $15.09
3/15/2022346,300 shares $107,353.00 +33.5%N/A0.7 $0.31
2/28/20224,040,000 shares $64.11 million -15.1%6.5%4.7 $15.87
2/28/2022259,400 shares $94,706.94 -59.0%N/A0.5 $0.37
2/15/20224,760,000 shares $68.07 million +24.6%7.6%4.9 $14.30
2/15/2022633,000 shares $294,978.00 -25.4%N/A1 $0.47
1/31/20223,820,000 shares $53.82 million +15.8%6.3%4.4 $14.09
1/31/2022849,000 shares $352,335.00 -5.2%N/A1.2 $0.42
1/15/20223,300,000 shares $45.01 million +2.5%5.4%4.5 $13.64
1/15/2022895,100 shares $428,752.90 +15.6%N/A0.9 $0.48
12/31/20213,220,000 shares $45.08 million -9.0%5.2%5.1 $14.00
12/31/2021774,500 shares $394,995.00 -14.3%N/A0.5 $0.51
12/15/20213,540,000 shares $46.62 million +1.7%5.7%5.6 $13.17
12/15/2021903,500 shares $575,529.50 -15.6%N/A0.4 $0.64
11/30/20213,480,000 shares $48.58 million -7.5%5.7%5.7 $13.96
11/30/20211,070,000 shares $749,000.00 +33.8%N/A0.5 $0.70
11/15/20213,760,000 shares $65.65 million -40.8%6.1%6.1 $17.46
11/15/2021799,600 shares $699,650.00 +148.9%N/A0.4 $0.88
10/29/20216,350,000 shares $104.27 million -2.0%10.4%11 $16.42
10/29/2021321,300 shares $280,494.90 -64.6%N/A0.2 $0.87
10/15/20216,480,000 shares $116.77 million -8.0%10.6%11.7 $18.02
10/15/2021907,100 shares $784,641.50 +24.2%N/A0.6 $0.87
9/30/20217,040,000 shares $131.86 million -1.7%11.5%11.9 $18.73
9/30/2021730,500 shares $628,376.10 -30.4%N/A0.8 $0.86
9/15/20217,160,000 shares $144.49 million -21.9%11.7%10.7 $20.18
9/15/20211,050,000 shares $1.41 million -14.6%3.9%1.3 $1.34
8/31/20219,170,000 shares $169.28 million +5.8%15.0%13 $18.46
8/31/20211,230,000 shares $1.87 million -1.6%4.5%1.8 $1.52
8/13/20218,670,000 shares $143.06 million +5.4%14.2%13.6 $16.50
8/13/20211,250,000 shares $1.94 million -2.3%4.6%1 $1.55
7/30/20218,230,000 shares $155.88 million +2.2%13.3%12.1 $18.94
7/30/20211,280,000 shares $1.97 million -21.0%4.7%1 $1.54
7/15/20218,050,000 shares $148.12 million -5.5%13.0%11.9 $18.40
7/15/20211,620,000 shares $2.61 million +22.7%5.9%1.3 $1.61
6/30/20218,520,000 shares $177.64 million -0.5%13.7%12.3 $20.85
6/30/20211,320,000 shares $3.00 million +13.8%4.8%1 $2.27
6/15/20218,560,000 shares $192.60 million +1.7%13.8%12.7 $22.50
6/15/20211,160,000 shares $2.12 million -35.2%4.3%1.4 $1.83
5/28/20218,420,000 shares $187.35 million -11.3%13.6%13.4 $22.25
5/28/20211,790,000 shares $2.88 million +506.0%6.6%2.2 $1.61
5/14/20219,490,000 shares $237.25 million +1.2%N/A12.1 $25.00
5/14/2021295,400 shares $384,020.00 -43.7%1.1%0.9 $1.30
4/30/20219,380,000 shares $257.86 million +6.6%N/A12.9 $27.49
4/30/2021524,300 shares $718,291.00 -15.8%2.0%0.7 $1.37
4/15/20218,800,000 shares $256.96 million -3.8%N/A11.7 $29.20
4/15/2021622,600 shares $1.00 million +1.5%2.5%0.6 $1.61
3/31/20219,150,000 shares $243.48 million +0.6%N/A12.3 $26.61
3/31/2021613,300 shares $1.09 million -32.9%2.5%0.6 $1.77
3/15/20219,100,000 shares $268.45 million +28.2%N/A11.6 $29.50
3/15/2021914,600 shares $1.97 million +4.7%3.7%0.8 $2.15
2/26/20217,100,000 shares $190.85 million +17.0%N/A7.6 $26.88
2/26/2021873,600 shares $1.73 million -4.6%3.7%0.8 $1.98
2/12/20216,070,000 shares $212.09 million +13.9%N/A7.3 $34.94
2/12/2021915,700 shares $2.36 million +53.4%3.9%0.8 $2.58
1/29/20215,330,000 shares $167.15 million -5.2%N/A6.4 $31.36
1/29/2021597,000 shares $1.13 million +285.4%3.3%0.7 $1.90
1/15/20215,620,000 shares $194.73 million -4.3%N/A6.7 $34.65
1/15/2021154,900 shares $215,311.00 No Change0.9%0.3 $1.39
12/31/20205,870,000 shares $199.52 million +15.8%N/A7 $33.99
12/15/20205,070,000 shares $209.59 million +8.3%N/A6.1 $41.34
11/30/20204,680,000 shares $170.26 million +8.1%N/A5.9 $36.38
11/15/20204,330,000 shares $173.03 million +25.9%N/A6 $39.96
10/30/20203,440,000 shares $109.91 million +8.5%N/A5 $31.95
10/15/20203,170,000 shares $105.97 million +5.7%N/A4.8 $33.43
9/30/20203,000,000 shares $91.92 million -22.5%N/A4.9 $30.64
9/15/20203,870,000 shares $109.64 million -5.2%N/A6.3 $28.33
8/31/20204,080,000 shares $101.55 million +3.3%N/A6.8 $24.89
8/31/2020434,400 shares $582,096.00 +32.4%N/A0.4 $1.34
8/14/20203,950,000 shares $82.91 million -1.5%N/A7 $20.99
8/14/2020328,000 shares $380,480.00 +33.0%N/A0.3 $1.16
7/31/2020246,600 shares $234,270.00 +55.7%N/A0.2 $0.95
7/31/20204,010,000 shares $65.92 million -1.5%N/A7.1 $16.44
7/15/20204,070,000 shares $72.93 million +6.8%9.7%5.4 $17.92
7/15/2020158,400 shares $107,712.00 -25.2%N/A0.2 $0.68
6/30/20203,810,000 shares $63.21 million +34.6%9.1%5.2 $16.59
6/30/2020211,700 shares $142,918.67 -53.8%N/A0.3 $0.68
6/15/20202,830,000 shares $47.83 million +2.5%6.7%3.9 $16.90
6/15/2020458,100 shares $508,491.00 +14.7%N/A0.8 $1.11
5/29/20202,760,000 shares $45.95 million -1.4%6.7%4.1 $16.65
5/29/2020399,400 shares $411,382.00 +20.3%N/A1 $1.03
5/15/20202,800,000 shares $42.84 million +2.6%6.8%4.2 $15.30
5/15/2020332,000 shares $209,359.20 +7.1%N/A1.2 $0.63
4/30/20202,730,000 shares $39.72 million +7.9%6.6%4.7 $14.55
4/30/2020310,000 shares $169,663.00 -10.2%N/A1.6 $0.55
4/15/20202,530,000 shares $25.20 million -11.2%6.1%7.6 $9.96
4/15/2020345,100 shares $176,760.22 +7.6%N/A1.8 $0.51
3/31/20202,850,000 shares $30.15 million -1.9%6.9%8.2 $10.58
3/31/2020320,700 shares $127,702.74 +2.6%N/A1.6 $0.40
3/13/20202,904,900 shares $28.18 million +3.8%7.0%8.1 $9.70
3/13/2020312,600 shares $136,762.50 +6.0%N/A2.6 $0.44
2/28/20202,800,000 shares $22.06 million +2.6%6.8%9 $7.88
2/28/2020295,000 shares $141,954.00 -0.2%N/A1.3 $0.48
2/14/20202,730,000 shares $28.91 million +1.1%6.6%9.4 $10.59
2/14/2020295,600 shares $162,580.00 +11.2%N/A0.7 $0.55
1/31/20202,700,000 shares $32.43 million +6.7%6.5%9.6 $12.01
1/31/2020265,800 shares $142,335.90 -31.1%N/A0.5 $0.54

KURA Short Interest - Frequently Asked Questions

What is Kura Oncology's current short interest?

Short interest is the volume of Kura Oncology shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 10,440,000 shares of KURA short. 16.00% of Kura Oncology's shares are currently sold short. Learn More on Kura Oncology's current short interest.

What is a good short interest ratio for Kura Oncology?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KURA shares currently have a short interest ratio of 6.0. Learn More on Kura Oncology's short interest ratio.

Which institutional investors are shorting Kura Oncology?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kura Oncology: Walleye Trading LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Kura Oncology?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.00% of Kura Oncology's floating shares are currently sold short.

Is Kura Oncology's short interest increasing or decreasing?

Kura Oncology saw a increase in short interest in December. As of December 31st, there was short interest totaling 10,440,000 shares, an increase of 17.4% from the previous total of 8,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Kura Oncology's float size?

Kura Oncology currently has issued a total of 77,760,000 shares. Some of Kura Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kura Oncology currently has a public float of 65,230,000 shares.

How does Kura Oncology's short interest compare to its competitors?

16.00% of Kura Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kura Oncology: Protagonist Therapeutics, Inc. (6.38%), Vera Therapeutics, Inc. (14.59%), CG Oncology, Inc. (16.39%), Harmony Biosciences Holdings, Inc. (14.10%), Mirum Pharmaceuticals, Inc. (13.39%), Beam Therapeutics Inc. (11.87%), Centessa Pharmaceuticals plc (4.03%), Mesoblast Limited (1.57%), IDEAYA Biosciences, Inc. (12.92%), Agios Pharmaceuticals, Inc. (10.03%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Kura Oncology stock?

Short selling KURA is an investing strategy that aims to generate trading profit from Kura Oncology as its price is falling. KURA shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Kura Oncology?

A short squeeze for Kura Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KURA, which in turn drives the price of the stock up even further.

How often is Kura Oncology's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KURA, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:KURA) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners